Canada startup’s portable x-ray may replace lung cancer CT scans

KA imaging, a startup company in Ontario, Canada, has developed a portable imaging device called a high-resolution, multi-energy x-ray that may transform lung cancer screening. The device allows health care providers to look at an image of the body in different layers (bone versus soft tissue) to get a clearer image of the lungs, the CBC reported Nov. 15.  

The device, which the company hopes could replace the need for CT scans and decrease radiation risk, is being tested for lung cancer screening at Grand River Hospital in Ontario.  

"The reason from a clinical point of view why that's important is a lot of time the cancer is going to be hiding behind the rib cage, especially near the top of the lungs or the apex of the lungs, where it's covered by some of the bones," Amol Karnick, president and CEO of KA Imaging, told CBC

The study at Grand River Hospital will involve up to 30 patients who have been diagnosed with cancer or lung nodules and are currently being monitored by the imaging department, according to the article.  

"It's faster, there is less cost than a CT scan and it's a portable technology as well, so it could be brought to the patients. So if there are patients that could not be moved in different areas of the hospital, this is a mobile device that can be taken to the patients," Carla Girolametto, director of research, innovation and clinical trials at Grand River Hospital, told CBC.  

Read the entire article below.  

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.